The Journal of Allergy and Clinical Immunology
Volume 116, Issue 3 , Pages 705-706 , September 2005

Topical viscous budesonide suspension for treatment of eosinophilic esophagitis

  • Seema S. Aceves, MD, PhD

      Affiliations

    • Division of Allergy, Immunology, Children's Hospital, San Diego, 3020 Children's Way MC-5114, San Diego, Calif 92123
    • Department of Pediatrics, University of California, San Diego, La Jolla, Calif
    • ,
  • Ranjan Dohil, MD

      Affiliations

    • Division of Pediatric Gastroenterology, University of California, San Diego, Calif
    • ,
  • Robert O. Newbury, MD

      Affiliations

    • Division of Pathology, Children's Hospital, San Diego, San Diego, Calif
    • ,
  • John F. Bastian, MD

      Affiliations

    • Division of Allergy, Immunology, Children's Hospital, San Diego, 3020 Children's Way MC-5114, San Diego, Calif 92123
    • Department of Pediatrics, University of California, San Diego, La Jolla, Calif

References 

  1. Rothenberg ME. Eosinophilic gastrointestinal disorders. J Allergy Clin Immunol. 2004;113:11–28
  2. Fogg MJ, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol. 2003;112:796–797
  3. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;351:940–941
  4. Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology?. J Allergy Clin Immunol. 2005;115:418–419
  5. Teitelbaum JE, Fox VL, Twarog FJ, Nurko S, Ntonioli D, Gleich G, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002;122:1216–1225
  6. Guajardo JR, Plotnick LM, Fende JM, Collins MH, Putnam PE, Rothenberg ME. Eosinophil-associated gastrointestinal disorders: a World-Wide Web based registry. J Pediatr. 2002;141:576–581
  7. Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol. 2004;113:115–119

 Disclosure of potential conflict of interest: None disclosed.

PII: S0091-6749(05)01306-0

doi: 10.1016/j.jaci.2005.05.011

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 3 , Pages 705-706 , September 2005

Article Tools